Perceptive Advisors as of Sept. 30, 2012
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 77 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals (INFIQ) | 14.2 | $63M | 2.7M | 23.51 | |
| Repros Therapeutics | 9.9 | $44M | 2.9M | 15.23 | |
| Neurocrine Biosciences (NBIX) | 6.7 | $29M | 3.7M | 7.98 | |
| Sarepta Therapeutics (SRPT) | 6.7 | $29M | 1.9M | 15.53 | |
| Aegerion Pharmaceuticals | 5.8 | $26M | 1.7M | 14.82 | |
| Neptune Technologies Bioreso | 4.5 | $20M | 5.0M | 3.95 | |
| Gilead Sciences (GILD) | 4.1 | $18M | 273k | 66.33 | |
| Capital Senior Living Corporation | 4.0 | $18M | 1.2M | 14.47 | |
| ViroPharma Incorporated | 4.0 | $17M | 576k | 30.19 | |
| Mylan | 3.0 | $13M | 534k | 24.37 | |
| Shire | 2.4 | $11M | 120k | 88.70 | |
| Express Scripts Holding | 2.3 | $10M | 164k | 62.63 | |
| athenahealth | 2.1 | $9.2M | 100k | 91.77 | |
| Celgene Corporation | 1.8 | $7.7M | 101k | 76.40 | |
| Onyx Pharmaceuticals | 1.4 | $5.9M | 70k | 84.50 | |
| Synta Pharmaceuticals | 1.3 | $5.7M | 742k | 7.62 | |
| Covidien | 1.2 | $5.4M | 92k | 59.42 | |
| Medivation | 1.2 | $5.2M | 93k | 56.34 | |
| Dyax Corp | 1.1 | $5.0M | 1.9M | 2.60 | |
| EXACT Sciences Corporation (EXAS) | 1.1 | $5.0M | 455k | 11.00 | |
| PROLOR Biotech | 1.1 | $4.7M | 970k | 4.85 | |
| Merck & Co (MRK) | 1.0 | $4.5M | 101k | 45.09 | |
| Novartis (NVS) | 1.0 | $4.3M | 71k | 61.26 | |
| Amgen | 1.0 | $4.2M | 50k | 84.29 | |
| Conceptus | 0.9 | $4.0M | 196k | 20.31 | |
| Celsion Corporation | 0.9 | $3.8M | 700k | 5.44 | |
| Orexigen Therapeutics | 0.8 | $3.6M | 636k | 5.71 | |
| Brookdale Senior Living (BKD) | 0.8 | $3.4M | 146k | 23.22 | |
| DepoMed | 0.7 | $3.3M | 550k | 5.91 | |
| Protalix BioTherapeutics | 0.7 | $2.9M | 564k | 5.18 | |
| Cutera | 0.7 | $2.9M | 393k | 7.46 | |
| ISIS Pharmaceuticals | 0.6 | $2.8M | 200k | 14.07 | |
| Keryx Biopharmaceuticals | 0.6 | $2.8M | 987k | 2.82 | |
| Uroplasty | 0.6 | $2.7M | 720k | 3.81 | |
| NPS Pharmaceuticals | 0.6 | $2.7M | 288k | 9.25 | |
| Anthera Pharmaceuticals | 0.6 | $2.5M | 2.6M | 0.99 | |
| Neostem (NBS) | 0.5 | $2.3M | 3.3M | 0.69 | |
| Questcor Pharmaceuticals | 0.5 | $2.2M | 120k | 18.48 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $2.3M | 40k | 55.88 | |
| Lexicon Pharmaceuticals | 0.5 | $2.1M | 900k | 2.32 | |
| Athersys | 0.5 | $2.0M | 1.5M | 1.39 | |
| Affymax (AFFY) | 0.4 | $1.9M | 91k | 21.06 | |
| Transgenomic | 0.4 | $1.9M | 2.0M | 0.95 | |
| Vivus | 0.4 | $1.8M | 100k | 17.81 | |
| MAKO Surgical | 0.4 | $1.8M | 102k | 17.41 | |
| Jazz Pharmaceuticals (JAZZ) | 0.4 | $1.7M | 30k | 56.99 | |
| Cadence Pharmaceuticals | 0.3 | $1.5M | 385k | 3.92 | |
| Pharmacyclics | 0.3 | $1.3M | 20k | 64.50 | |
| Amarin Corporation | 0.3 | $1.3M | 100k | 12.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $1.1M | 20k | 55.90 | |
| Thoratec Corporation | 0.2 | $1.0M | 30k | 34.60 | |
| Sunrise Senior Living | 0.2 | $1.0M | 73k | 14.27 | |
| Achillion Pharmaceuticals | 0.2 | $1.1M | 101k | 10.41 | |
| Star Scientific | 0.2 | $917k | 265k | 3.46 | |
| Vical Incorporated | 0.2 | $866k | 200k | 4.33 | |
| Ironwood Pharmaceuticals (IRWD) | 0.2 | $771k | 60k | 12.78 | |
| DARA BioSciences | 0.2 | $788k | 750k | 1.05 | |
| Mgc Diagnostics | 0.2 | $744k | 123k | 6.05 | |
| Oncothyreon | 0.2 | $710k | 138k | 5.13 | |
| XOMA CORP Common equity shares | 0.2 | $707k | 192k | 3.69 | |
| Greenway Medical Technology | 0.1 | $657k | 38k | 17.11 | |
| ProShares Ultra S&P500 (SSO) | 0.1 | $612k | 10k | 61.20 | |
| INSTRS INC Stemcells | 0.1 | $477k | 232k | 2.06 | |
| Spectranetics Corporation | 0.1 | $296k | 20k | 14.73 | |
| Trinity Biotech | 0.1 | $279k | 22k | 12.59 | |
| Exelixis (EXEL) | 0.1 | $241k | 50k | 4.82 | |
| Emeritus Corporation | 0.1 | $211k | 10k | 20.89 | |
| D Horizon Pharma | 0.0 | $175k | 50k | 3.50 | |
| Celldex Therapeutics | 0.0 | $146k | 23k | 6.32 | |
| Senesco Technologies | 0.0 | $133k | 634k | 0.21 | |
| Verastem | 0.0 | $111k | 12k | 9.39 | |
| BioMimetic Therapeutics | 0.0 | $109k | 26k | 4.13 | |
| Aastrom Biosciences | 0.0 | $109k | 67k | 1.64 | |
| Watson Pharmaceuticals | 0.0 | $26k | 300.00 | 86.67 | |
| Genvec | 0.0 | $22k | 14k | 1.58 | |
| Amicus Therapeutics (FOLD) | 0.0 | $2.0k | 300.00 | 6.67 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $5.0k | 50k | 0.10 |